Advance Directives Completion Rates and an Intervention to Address Health Literacy in a Clinic Population

November 15, 2018 updated by: University of Florida

The ability to communicate with patients is profoundly impacted by their health literacy - the ability to interpret documents, read and write prose, use quantitative information and speak and listen effectively. Limited health literacy is commonplace and associated with multiple poor health outcomes including frequent readmission's and high mortality. Advance directives are an important tool in respecting patient autonomy in health care interventions. Advance directives can also reduce health care costs by avoiding unwanted, unnecessary care at the end of life. At the University of Florida (UF) Health currently an initiative is underway to improve the delivery of advance directives to patients in the hospital as well as the outpatient clinics.

The aim of this research study is to enhance completion rates of advance directives by taking into consideration a patient's health literacy level. Specifically, the investigators plan to assess the impact of an ambulatory intervention on the completion rate of advance directives for patients with adequate and limited health literacy. The hypothesis is that both groups (adequate and limited health literacy) will benefit from the intervention, but patients with limited health literacy will show a greater improvement in the advance directives completion rate.

Study Overview

Detailed Description

The purpose of this research study is to improve completion of Advance Directives. These are documents that patients use to let doctors know what their wishes for treatment are and who they would want to make decisions for them if they could not make decisions for themselves.

At the time of the clinic visit to the Internal Medicine at Medical Plaza (IMMP) or the Internal Medicine at Tower Hill (IMTH) subjects will be invited to participate in the study.

Research Assistant(s) RA Responsibilities:

All Potential Study Subjects:

  1. RA will interview study subject in a private area (exam room or empty office).
  2. RA will assess eligibility criteria.
  3. RA will obtain informed consent.
  4. RA will randomize the subjects to either intervention or control.
  5. RA will explain to the subjects how to return the advance directive (AD)

For the Intervention group:

  1. RA will review and walk through the University of Florida (UF) AD brochure
  2. RA will offer subjects a link to a patient education video on advance directives. The link will be texted or emailed or given in paper per the subject's preference.
  3. RA will conduct a brief satisfaction questionnaire addressing the activity review of the UF AD brochure.
  4. RA will ask

    1. Did addressing advance directives enhance today's experience at the clinic?
    2. Do you think that advance directives be routinely addressed at visits to the doctor?

Control group:

If the subject is ready to complete an advance directive they will be referred to clinic staff for assistance.

RA will ask

  1. Did addressing advance directives enhance today's experience at the clinic?
  2. Do you think that advance directives should be routinely addressed at visits to the doctor?

Study Type

Interventional

Enrollment (Actual)

529

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32607
        • Tower Hill Internal Medicine
      • Gainesville, Florida, United States, 32610
        • Internal Medicine at Medical Plaza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

51 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • No advance directive in electronic medical record,
  • speaks English,
  • has intact cognitive function

Exclusion Criteria:

  • Age 50 or under,
  • already has an advance directive in electronic medical record,
  • does not speak English,
  • cognitive dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Adequate health literacy, control
This group of subjects will be referred to clinic staff for assistance with the advance directives (AD) and will not receive assistance from a research assistant. In addition, the research assistance will ask questions regarding the information received for the AD.
This group of subjects will be provided with the advance directive and then referred to clinic staff for assistance.
Other Names:
  • Living will
Experimental: Adequate health literacy, intervention
The subjects in this group will hear a research assistant review the advance directive and be offered an opportunity to watch a video about advance directives.
These subject's will have a research assistant (RA) review and walk through the advance directives brochure. The RA will read all of the brochure to the patient and prompt for questions. In addition, a link to an educational video on advance directives. The advance directive link will be either texted or emailed or given in paper per the subject's preference.
Other Names:
  • Living will
Other: Limited health literacy, control
This group of subjects will be referred to clinic staff for assistance with the advance directives (AD) and will not receive assistance from a research assistant. In addition, the research assistance will ask questions regarding the information received for the AD.
This group of subjects will be provided with the advance directive and then referred to clinic staff for assistance.
Other Names:
  • Living will
Experimental: Limited health literacy, intervention
The subjects in this group will hear a research assistant review the advance directive and be offered an opportunity to watch a video about advance directives.
These subject's will have a research assistant (RA) review and walk through the advance directives brochure. The RA will read all of the brochure to the patient and prompt for questions. In addition, a link to an educational video on advance directives. The advance directive link will be either texted or emailed or given in paper per the subject's preference.
Other Names:
  • Living will

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of advance directive scanned into electronic medical record
Time Frame: 6 months from enrollment
The research assistant will review the subject's electronic medical record for a copy of a signed advance directive.
6 months from enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of reminder phone calls needed
Time Frame: 6 months
  1. All subjects' charts will be reviewed to see if the subjects have submitted AD.
  2. If a subject has not submitted an AD, the RA will remind them to return their advance directive papers via phone call 1, 3 and 5 months after they are enrolled
6 months
Client Evaluation of Services Questionnaire
Time Frame: day of study

Score 8 - 32

  1. How would you rate the quality of services you have received at your visit today?
  2. Did you get the kind of service you wanted?
  3. To what extent has your visit met your needs?
  4. If a friend were in need of similar help, would you recommend our office to him or her?
  5. How satisfied are you with the amount of help you have received?
  6. Have the services you receive helped you to deal more effectively with your problems?
  7. In an overall, general sense, how satisfied are you with the service you have received at the visit?
  8. If you were to seek help again, would you come back to our office?
  9. Did addressing Advance Directives enhance your clinic experience today?
  10. Do you think Advance Directives should be routinely addressed at your doctor's visit?
day of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melanie G Hagen, MD, University of Florida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2017

Primary Completion (Actual)

November 15, 2018

Study Completion (Actual)

November 15, 2018

Study Registration Dates

First Submitted

February 29, 2016

First Submitted That Met QC Criteria

March 2, 2016

First Posted (Estimate)

March 8, 2016

Study Record Updates

Last Update Posted (Actual)

November 19, 2018

Last Update Submitted That Met QC Criteria

November 15, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • IRB201500776

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Literacy

Clinical Trials on Advance Directives without assistance

3
Subscribe